Abstract:Introduction: Overcoming the challenge of low solubility in pharmaceutical research is critical, particularly for poorly soluble drugs. This study focuses on the development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) based on alginate, intending to enhance the solubility of fenofibrate, a BCS class II drug known for its low aqueous solubility. Methods and materials: The process of formulation optimization involved the preparation of SNEDDS formulations using varying proportions of oleic acid (as the oily phase), Tween 80 (as the surfactant), and PEG 400 (as the cosurfactant). A ternary graph depicting oil-water and surfactant/cosurfactant combinations was constructed to analyze different formulations. Dynamic light diffraction determined the formulations' particle size and polydispersity index. Based on these results, four SNEDDS formulations were selected for further investigation. Different ratios of alginate, an adhesive mucus polymer, were incorporated into these formulations. The particle size, polydispersity index, and light transmission were measured for each formulation with varying alginate ratios. Optimal alginate ratios were selected based on these measurements. The solubility of fenofibrate was also assessed in a solution without polymer. Rheology tests were performed on formulations in the absence and presence of polymer using the selected alginate ratios. Validation studies were performed according to the US Pharmacopoeia for fenofibrate, with accuracy determined by measuring the absorbance of standard samples at different concentrations and precision calculated by analyzing the mean value and standard deviation. The physical stability of the selected formulations was evaluated over three months at room temperature. The fenofibrate release pattern from the SNEDDS was also conducted using the dialysis method with a cellulose membrane dialysis bag in the simulated gastric and intestinal environments without GI enzymes. Results: The results demonstrated that the optimized SNEDDS formulations, comprising appropriate amounts of oleic acid, Tween 80/PEG 400 surfactant mixture, and alginate polymer, exhibited desirable particle sizes ranging from 149.9 to 210.6 nm and polydispersity index values between 0.314 and 0.451. Rheological analysis indicated increased viscosity with the addition of alginate. In vitro drug release studies revealed a sustained release pattern for polymer-containing formulations compared to polymer-free formulations, with 102 mg/g solution rates and 124 mg/g for the two final formulations. Moreover, the nanosystem formulation significantly improved the dissolution rate of fenofibrate compared to the free drug form in both simulated gastric and intestinal environments. Conclusion and discussion: The developed alginate-based self-nano emulsifying system shows promise in enhancing fenofibrate's solubility and dissolution rate. This research contributes to exploring novel strategies for improving the bioavailability of poorly soluble drugs.

Development, in vitro and in vivo evaluation of β-cyclodextrin/Polyvinyl alcohol-co-poly (2-acrylamide-2-methylpropane sulfonic acid) cross-linked hybrid IPN-nanogels to improve the dissolution and absorption of anti-hyperlipidemic drug

Enhancing solubility and oral bioavailability of rosuvastatin through interpenetrating polymer network (IPN) nanogels: Fabrication, characterization, and in-vivo efficacy assessment

Structural and in-vitro characterization of highly swellable β-cyclodextrin polymeric nanogels fabricated by free radical polymerization for solubility enhancement of rosuvastatin

Fabrication and evaluation of cross-linked nanogels of Dexibuprofen

Development and in vitro evaluation of (β-cyclodextrin-g-methacrylic acid)/Na+-montmorillonite nanocomposite hydrogels for controlled delivery of lovastatin

Formulation and evaluation of polyethylene glycol/Xanthan gum-co-poly (Acrylic acid) interpenetrating network for controlled release of venlafaxine

Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System

Preparation and characterization of alginate-PVA-based semi-IPN: controlled release pH-responsive composites

In Vitro and In Vivo Evaluation of Hydroxypropyl-β-cyclodextrin-grafted-poly(acrylic acid)/poly(vinyl pyrrolidone) Semi-Interpenetrating Matrices of Dexamethasone Sodium Phosphate

Crosslinked Poly(vinyl Alcohol) Hydrogel Microspheres Containing Dispersed Fenofibrate Nanocrystals As an Oral Sustained Delivery System

Development and Characterization of an Alginate-Based Self-Nanoemulsifying System for Enhanced Solubility of Fenofibrate

New Molecular Imprinting Nano Polymer Synthesis And Characterization As A Biocompatible For Drug Delivery Applications

Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin

Crosslinked PVA- g -poly(AMPS) Nanogels for Enhanced Solubility and Dissolution of Ticagrelor: Synthesis, Characterization, and Toxicity Evaluation

Hydrogel Containing Solid Lipid Nanoparticles Loaded with Argan Oil and Simvastatin: Preparation, In Vitro and Ex Vivo Assessment

Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement

Preparation of Temperature‐sensitive Poly(n‐isopropylacrylamide)/β‐cyclodextrin‐grafted Polyethylenimine Hydrogels for Drug Delivery

Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation

Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement

Preparation, In Vitro Characterization, and Evaluation of Polymeric pH-Responsive Hydrogels for Controlled Drug Release

Polycaprolactone diacrylate crosslinked biodegradable semi-interpenetrating networks of polyacrylamide and gelatin for controlled drug delivery